WallStreetZenWallStreetZen

NASDAQ: PROC
Procaps Group Sa Stock

$2.70+0.02 (+0.75%)
Updated Apr 18, 2024
PROC Price
$2.70
Fair Value Price
$8.03
Market Cap
$304.63M
52 Week Low
$1.95
52 Week High
$5.38
P/E
5.19x
P/B
7.73x
P/S
0.99x
PEG
N/A
Dividend Yield
N/A
Revenue
$414.10M
Earnings
$52.20M
Gross Margin
55%
Operating Margin
14.03%
Profit Margin
12.6%
Debt to Equity
11.68
Operating Cash Flow
$74M
Beta
0.01
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PROC Overview

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PROC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PROC ($2.70) is undervalued by 66.39% relative to our estimate of its Fair Value price of $8.03 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PROC ($2.70) is significantly undervalued by 66.39% relative to our estimate of its Fair Value price of $8.03 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PROC was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PROC due diligence checks available for Premium users.

Be the first to know about important PROC news, forecast changes, insider trades & much more!

PROC News

Valuation

PROC fair value

Fair Value of PROC stock based on Discounted Cash Flow (DCF)
Price
$2.70
Fair Value
$8.03
Undervalued by
66.39%
PROC ($2.70) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PROC ($2.70) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PROC was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PROC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
5.19x
Industry
46.58x
Market
41.33x
PROC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PROC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

PROC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.73x
Industry
2.04x
PROC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PROC's financial health

Profit margin

Revenue
$118.4M
Net Income
$8.2M
Profit Margin
6.9%
PROC's Earnings (EBIT) of $58.12M... subscribe to Premium to read more.
Interest Coverage Financials
PROC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$498.6M
Liabilities
$460.1M
Debt to equity
11.68
PROC's short-term assets ($298.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PROC's short-term assets ($298.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PROC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$48.7M
Investing
-$7.5M
Financing
-$29.9M
PROC's operating cash flow ($73.74M)... subscribe to Premium to read more.
Debt Coverage Financials

PROC vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PROC$304.63M+0.75%5.19x7.73x
ACB$311.00M+12.87%-1.65x0.81x
KMDA$293.15M+0.39%30.00x1.20x
AQST$329.86M+14.80%-34.62x-3.10x
ESPR$346.05M+1.63%-0.92x-0.76x

Procaps Group Sa Stock FAQ

What is Procaps Group Sa's quote symbol?

(NASDAQ: PROC) Procaps Group Sa trades on the NASDAQ under the ticker symbol PROC. Procaps Group Sa stock quotes can also be displayed as NASDAQ: PROC.

If you're new to stock investing, here's how to buy Procaps Group Sa stock.

What is the 52 week high and low for Procaps Group Sa (NASDAQ: PROC)?

(NASDAQ: PROC) Procaps Group Sa's 52-week high was $5.38, and its 52-week low was $1.95. It is currently -49.81% from its 52-week high and 38.46% from its 52-week low.

How much is Procaps Group Sa stock worth today?

(NASDAQ: PROC) Procaps Group Sa currently has 112,824,183 outstanding shares. With Procaps Group Sa stock trading at $2.70 per share, the total value of Procaps Group Sa stock (market capitalization) is $304.63M.

Procaps Group Sa stock was originally listed at a price of $10.10 in Oct 18, 2019. If you had invested in Procaps Group Sa stock at $10.10, your return over the last 4 years would have been -73.27%, for an annualized return of -28.09% (not including any dividends or dividend reinvestments).

How much is Procaps Group Sa's stock price per share?

(NASDAQ: PROC) Procaps Group Sa stock price per share is $2.70 today (as of Apr 18, 2024).

What is Procaps Group Sa's Market Cap?

(NASDAQ: PROC) Procaps Group Sa's market cap is $304.63M, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Procaps Group Sa's market cap is calculated by multiplying PROC's current stock price of $2.70 by PROC's total outstanding shares of 112,824,183.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.